Stocks and Investing
Stocks and Investing
Mon, February 25, 2013
[ 07:49 AM ] - WOPRAI
[ 07:49 AM ] - WOPRAI
[ 07:48 AM ] - WOPRAI
[ 07:48 AM ] - WOPRAI
[ 07:48 AM ] - WOPRAI
[ 07:48 AM ] - WOPRAI
[ 07:47 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:46 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 07:45 AM ] - WOPRAI
[ 06:45 AM ] - WOPRAI
[ 05:49 AM ] - Market Wire
[ 05:19 AM ] - Market Wire
[ 05:07 AM ] - Market Wire
[ 05:00 AM ] - Market Wire
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Christopher Raymond Maintained (AMGN) at Buy with Increased Target to $107 on, Feb 25th, 2013
Christopher Raymond of Piper Sandler, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $104 to $107 on, Feb 25th, 2013.
Christopher has made no other calls on AMGN in the last 4 months.
There are 2 other peers that have a rating on AMGN. Out of the 2 peers that are also analyzing AMGN, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $91 on, Thursday, December 13th, 2012
This is the rating of the analyst that currently disagrees with Christopher
- David Toung of "Argus Research" Upgraded from Hold to Strong Buy on, Friday, January 25th, 2013